Gautam Janesh Kumar, Thanvi Anjali, Soni Purushotam, Anand Praveen K
Biotechnology, Indian Council of Medical Research-National Institute for Implementation Research on Noncommunicable Diseases, Jodhpur, IND.
Public Health, Indian Council of Medical Research-National Institute for Implementation Research on Noncommunicable Diseases, Jodhpur, IND.
Cureus. 2025 Mar 10;17(3):e80319. doi: 10.7759/cureus.80319. eCollection 2025 Mar.
Tuberculosis (TB) and diabetes mellitus (DM) comorbidity is a significant public health problem globally and in India. The present study estimated the proportion and determinants of DM among notified TB patients within the Indian National Tuberculosis Elimination Program (NTEP).
The present study is the secondary data analysis of the NTEP data obtained from the District Tuberculosis Office, Jaipur, Rajasthan, India. The total number of TB patients included in the study was 4679. Sociodemographic and clinical data were compared between TB-DM and TB-only patients. Bivariate chi-squared analysis and multivariate logistic regression analysis were employed to understand the determinants of TB-DM comorbidity.
The proportion of DM among the notified TB patients was found to be 0.98% (46). TB-DM patients were significantly older (a mean age of 51.6±12.4 years vs. 34.2±17.3 years; p<0.001) and had higher body weight (51.2±11.4 kg vs. 46.2±12.4 kg; p<0.05) than TB-only patients. Bivariate analysis revealed that males and individuals over 35 years of age had higher odds of TB-DM, with odds ratios of 1.906 (95% CI: 1.015-3.582) and 29.871 (95% CI: 7.233-123.363), respectively. Multivariate binary logistic regression analysis determined that age >=35 years was a significant determinant of TB-DM comorbidity (adjusted odds ratio (AOR): 28.641; 95% CI: 6.818-120.313; p<0.001). There was no significant association of treatment success rate and death rate with TB-DM comorbidity. The comparison of diagnostic and enrollment facilities in diagnosing and enrolling TB-DM revealed that the diagnostic and enrollment of TB-DM patients were higher in private healthcare facilities than in public healthcare facilities.
The study results determined that age >35 years is the significant determinant of TB-DM comorbidity. The analysis of diagnostic and enrollment facilities showed that TB-DM patients were more likely to be diagnosed and enrolled in private hospitals than government healthcare facilities. The study findings suggest that there is a need for integrated management approaches that address TB and DM concurrently.
结核病(TB)与糖尿病(DM)合并症是全球及印度的一个重大公共卫生问题。本研究估计了印度国家结核病消除计划(NTEP)中报告的结核病患者中糖尿病的比例及其决定因素。
本研究是对从印度拉贾斯坦邦斋浦尔区结核病办公室获取的NTEP数据进行的二次数据分析。纳入研究的结核病患者总数为4679例。对结核病合并糖尿病患者和单纯结核病患者的社会人口统计学和临床数据进行了比较。采用双变量卡方分析和多变量逻辑回归分析来了解结核病合并糖尿病的决定因素。
报告的结核病患者中糖尿病的比例为0.98%(46例)。结核病合并糖尿病患者明显年龄更大(平均年龄51.6±12.4岁 vs. 34.2±17.3岁;p<0.001),体重也更高(51.2±11.4 kg vs. 46.2±12.4 kg;p<0.05)。双变量分析显示,男性和35岁以上个体患结核病合并糖尿病的几率更高,优势比分别为1.906(95%置信区间:1.015 - 3.582)和29.871(95%置信区间:7.233 - 123.363)。多变量二元逻辑回归分析确定年龄≥35岁是结核病合并糖尿病的一个重要决定因素(调整优势比(AOR):28.641;95%置信区间:6.818 - 120.313;p<0.001)。治疗成功率和死亡率与结核病合并糖尿病之间无显著关联。对结核病合并糖尿病患者诊断和登记设施的比较显示,私立医疗机构中结核病合并糖尿病患者的诊断和登记率高于公立医疗机构。
研究结果确定年龄>35岁是结核病合并糖尿病的重要决定因素。对诊断和登记设施的分析表明,与政府医疗机构相比,结核病合并糖尿病患者更有可能在私立医院被诊断和登记。研究结果表明,需要采取同时应对结核病和糖尿病的综合管理方法。